Abbott India Reports Robust Q1 Performance with 11% Revenue Growth

1 min read     Updated on 12 Aug 2025, 01:34 PM
scanx
Reviewed by
Jubin VergheseBy ScanX News Team
whatsapptwittershare
Overview

Abbott India Limited announced robust Q1 FY2025 financial results. Revenue increased by 11.6% to ₹1,738.35 crore, while net profit grew 11.5% to ₹365.86 crore. EBITDA rose 14.1% to ₹445 crore, with the EBITDA margin improving to 25.63%. The company also appointed Mr. Darshan Gada as an Additional (Non-Executive) Director, effective August 18, 2025, subject to shareholder approval.

16531479

*this image is generated using AI for illustrative purposes only.

Abbott India Limited , a leading pharmaceutical company, has announced strong financial results for the first quarter, showcasing significant growth across key metrics.

Financial Highlights

The company's performance for Q1 demonstrated notable improvements:

Metric Q1 FY2025 Q1 FY2024 YoY Change
Revenue ₹1,738.35 ₹1,557.61 11.6%
Net Profit ₹365.86 ₹328.01 11.5%
EBITDA ₹445.00 ₹390.00 14.1%
EBITDA Margin 25.63% 25.10% 53 bps

Revenue Growth

Abbott India's revenue from operations increased to ₹1,738.35 crore, up from ₹1,557.61 crore in the same period last year, marking a robust 11.6% year-over-year growth. This growth reflects the company's strong market presence and effective business strategies.

Profitability

The company's net profit rose to ₹365.86 crore, compared to ₹328.01 crore in the previous year's quarter, representing an 11.5% increase. This improvement in profitability demonstrates Abbott India's ability to manage costs effectively while driving revenue growth.

Operational Efficiency

Abbott India's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) grew to ₹445 crore from ₹390 crore in the previous year, showing a 14.1% increase. The EBITDA margin also improved, rising to 25.63% from 25.10%, indicating enhanced operational efficiency and cost management.

Board Meeting Outcomes

In addition to the financial results, the company's Board of Directors approved the appointment of Mr. Darshan Gada as an Additional (Non-Executive) Director, effective August 18, 2025, subject to shareholder approval.

Mr. Gada brings over 21 years of extensive experience in finance, spanning commercial operations, taxation, supply chain finance, mergers & acquisitions, and strategy. His appointment is expected to contribute to Abbott India's financial planning and strategic growth initiatives.

Conclusion

Abbott India's Q1 results demonstrate the company's ability to deliver strong financial performance and operational improvements. With double-digit growth in revenue and profitability, along with strategic appointments to strengthen its leadership team, Abbott India appears well-positioned for continued success in the pharmaceutical sector.

Historical Stock Returns for Abbott

1 Day5 Days1 Month6 Months1 Year5 Years
+0.99%+1.67%-3.00%+19.49%+22.96%+101.99%

ABB India Faces Industrial Project Slowdown, Targets 12-15% Profit Margin for 2025

1 min read     Updated on 05 Aug 2025, 07:27 AM
scanx
Reviewed by
Radhika SahaniBy ScanX News Team
whatsapptwittershare
Overview

ABB India reported a record order backlog exceeding Rs 10,000 crore, with 90% of business from the domestic market. The company is experiencing cyclical challenges in its systems order segment due to customer delays. Q2 results showed a 20.7% decrease in net profit to Rs 351.70 crore, while revenue grew 12.2% to Rs 3,175.40 crore. EBITDA margin fell to 13% from 19.2%. Despite challenges, ABB India sees strong demand in tier-1, tier-2, and tier-3 markets, particularly in infrastructure, real estate, and data centers. The company aims for 12-15% profit margins by 2025.

15904656

*this image is generated using AI for illustrative purposes only.

ABB India , a major player in the industrial technology sector, is navigating through a temporary slowdown in its large-scale industrial projects segment while maintaining an optimistic outlook for the future. The company has set its sights on achieving profit margins between 12-15% in 2025, despite current challenges in the market.

Record Order Backlog Amid Domestic Focus

ABB India reported a significant milestone with its order backlog exceeding Rs 10,000 crore, highlighting the company's strong market position. Notably, 90% of the business is derived from the domestic market, underscoring ABB India's deep roots and substantial presence within the country.

Cyclical Challenges in Systems Order Segment

Managing Director Sanjeev Sharma shed light on the current situation, noting that the systems order segment, which handles heavy industry solutions, is experiencing cyclical challenges. These difficulties are primarily attributed to customer delays, stemming from uncertainty surrounding trade tariffs. This segment's performance has a notable impact on the company's overall financial results.

Q2 Financial Performance

The effects of these challenges were evident in ABB India's second-quarter financial results:

Metric Q2 Performance Year-over-Year Change
Net Profit Rs 351.70 crore -20.7%
Revenue Rs 3,175.40 crore +12.2%
EBITDA Rs 441.00 crore -27%
EBITDA Margin 13.00% Down from 19.2%

Despite the decline in net profit and EBITDA, the company managed to grow its revenue, indicating resilience in certain business areas.

Market Opportunities and Future Outlook

ABB India remains optimistic about demand in various market tiers:

  • Strong demand observed in tier-1, tier-2, and tier-3 markets
  • Particular growth noted in infrastructure, real estate, and data centers

These sectors present significant opportunities for ABB India to leverage its expertise and potentially offset challenges in other segments.

Stock Market Reaction

Investors responded to the news with caution, as ABB India's shares closed 5.34% lower at Rs 5,100.00 on the day of the announcement.

As ABB India navigates through this period of sectoral challenges, the company's strong order backlog and focus on maintaining healthy profit margins suggest a strategic approach to long-term stability and growth in the competitive industrial technology landscape.

Historical Stock Returns for Abbott

1 Day5 Days1 Month6 Months1 Year5 Years
+0.99%+1.67%-3.00%+19.49%+22.96%+101.99%
More News on Abbott India
Explore Other Articles
Government Mulls GST Cut on Insurance to Boost Coverage 8 minutes ago
Modi's Navnirman Limited Concludes Postal Ballot for Subsidiary Merger Scheme 13 minutes ago
Sandu Pharmaceuticals Reports 33.8% Jump in Q1 Net Profit Despite Revenue Decline 45 minutes ago
Dynacons Systems & Solutions Reports 10% Jump in Q1 FY2026 Net Profit, Declares Interim Dividend 1 hour ago
MRC Agrotech Inks Exclusive Bio-Fertilizer Distribution Deal with VedicTree 18 hours ago
33,265.00
+325.00
(+0.99%)